← Evidence map

ReviewHeart international2026

Aprocitentan: An oral, once-daily antihypertensive therapy for resistant hypertension in adult patients.

Patricia Otero Valdes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 42293060